Double-Blind Placebo-Controlled Randomized Clinical Trial of Neurofeedback for Attention-Deficit/Hyperactivity Disorder With 13-Month Follow-up: JAACAP July 2021

01/07/2021 22 min
Double-Blind Placebo-Controlled Randomized Clinical Trial of Neurofeedback for Attention-Deficit/Hyperactivity Disorder With 13-Month Follow-up: JAACAP July 2021

Listen "Double-Blind Placebo-Controlled Randomized Clinical Trial of Neurofeedback for Attention-Deficit/Hyperactivity Disorder With 13-Month Follow-up: JAACAP July 2021"

Episode Synopsis

JAACAP July 2021: Contributing Editor Dr. Jung W. Kim interviews Drs. L. Eugene Arnold and Roger deBeus on if theta/beta-ratio (TBR) electroencephalographic biofeedback (neurofeedback [NF]) has a specific effect on attention-deficit/hyperactivity disorder (ADHD) beyond nonspecific benefit.

More episodes of the podcast Journal of the American Academy of Child and Adolescent Psychiatry